Table 12.
Type | Source Cell/Tissue | Key Features |
---|---|---|
pNET spheroids | pNET cell lines: BON-1 and QGP-1 Human lung neuroendocrine cell line: H727 |
Three-dimensional spheroids start forming by day 3 of cell plating and contain highly proliferative cells at the periphery and a necrotic center, proposed to be useful models for in vitro drug screening [344]. |
SBNET spheroids | Patient SBNETs | Cultured with the help of extracellular matrix (Matrigel); doubling time was 14 days; expressed synaptophysin, chromogranin and SSTR2; undergo apoptosis with rapamycin treatment [345]. |
pNET spheroids | Patient pNETs | Primary tumor cells isolated from pNETs and cultured in vitro to form islet-like tumoroids that retain a neuroendocrine phenotype and are viable for at least 2 weeks in culture for drug testing [346]. |